期刊文献+

精神分裂症患者迟发性运动障碍与糖代谢异常关系探讨 被引量:5

Relationship between glycometabolism and tardive dyskinesia in schizophrenia patients
原文传递
导出
摘要 目的 探讨迟发性运动障碍(TD)与糖代谢之间可能存在的关系.方法 采用Simpson迟发性运动障碍专用量表筛选出符合入组标准的TD患者(TD组)30例和非TD患者(非TD组)32例,采用阳性与阴性症状评定量表(PANSS)评定精神病理症状的严重程度,采用异常不自主运动量表(AIMS)评定TD症状的严重程度,采用全自动生化仪测定同一时间患者空腹血糖、血清胰岛素、胰岛素抵抗指数、糖化血红蛋白,比较2组患者糖代谢指标的差异,并分析TD患者糖代谢指标水平与AIMS总分间的关系.结果 TD组空腹血糖[(5.74±1.36)mmol/L]高于非TD组[(5.05±0.91)mmol/L],差异有统计学意义(F=6.619,P=0.013);TD组患者AIMS评分与血清胰岛素(r=0.469)、空腹血糖(r=0.512)及胰岛素抵抗指数(r=0.483)呈正相关(P均<0.05).结论 TD组较非TD组糖代谢异常明显,糖代谢异常可能与TD的发生有一定关系. Objective To explore the relationship between glycometabolism and tardive dyskinesia in schizophrenia patients. Methods Thirty schizophrenia patients with TD and 32 without TD were recruited by using the Simpson dyskinesia scale. They were assessed with the Positive and Negative Symptom Scale ( PANSS ) and Abnormal Involuntary Movement Scale ( AIMS ) ( Chinese version ). The levels of FINS ( fasting insulin ), IRI( insulin resistance index ), GHB( glycolated hemoglobin )and FPG( fasting plasma glucose )were measured. The relationship between glycometabolism and TD was analysed. Results The levels of FPG were significantly higher in schizophrenia patients with TD [( 5.74 ± 1.36 )mmol/L] than the patients without TD[( 5.05 ± 0. 91 )mmol/L] ( F = 6. 619, P = 0. 013 ). The AIMS scores were positively correlated with levels of FINS( r = 0. 469, P 〈 0. 05 ), FPG( r = 0. 512, P 〈 0. 05 )and IRI( r = 0. 483, P 〈0. 05 ). Conclusions Glycometabolism may be involved in the pathophysiological process of TD.
出处 《中华精神科杂志》 CAS CSCD 北大核心 2011年第1期36-38,共3页 Chinese Journal of Psychiatry
关键词 运动障碍 药物性 精神分裂症 胰岛素 血糖 胰岛素抗药性 血红 蛋白类 Dyskinesia, drug-induced Schizophrenia Insulin Blood glucose Insulin resistance Hemoglobins
  • 相关文献

参考文献10

二级参考文献35

  • 1谭云龙,周东丰,邹义壮,车向宜.维生素E对迟发性运动障碍模型大鼠的影响[J].中华精神科杂志,2004,37(3):179-181. 被引量:11
  • 2徐贵森,刘合年,杨淑霞,代雪梅,张玉兰,刘英海.缺血再灌注脊髓丙二醛含量和超氧化物歧化酶活性的变化[J].西南军医,2006,8(2):10-11. 被引量:9
  • 3朱风艳,费立鹏,Jefrey A. Lieberman.长期住院病人的迟发性运动障碍调查[J].上海精神医学,1996,8(3):128-132. 被引量:6
  • 4颜文伟 康伟民 等.迟发性运动障碍的流行病学调查[J].上海精神医学,1986,4(4):192-192.
  • 5Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells[J]. Free Radio Biol Med ,2003,35( 11 ) : 1 491 - 1 499.
  • 6Mircescu G. Oxidative stress: an accomplice to uremic toxicity? [J].Ren Nutr,2006,16(3):194-198.
  • 7Lushchak VI. Free radical oxidation of proteins and its relationship with functional state of organisms[J]. Biol Chem (Mosc),2007,72(8):809-827.
  • 8Kanwar YS,Akagi S, Sun L,et al. Cell biology of diabetic kidney disease[J]. Nephron Exp Nephrol,2005,101 (3) : 100 - 107.
  • 9Thomas TP,Porcellati F,Kato K,et al. Effects of glucose on sorbitol pathway activation, cellular redox, and metabolism of myo inositol, phosphoinositide, and diacylglycerol in cultured human retinal pigment epithelial cells [_J ]. Clin Invest, 1994,93(6):2 718- 2 724.
  • 10Robertson RP. Chronic oxidative stress central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes[J]. Biol Chem ,2004,279(41 ) :42 351 - 42 354.

共引文献65

同被引文献71

  • 1谭云龙,周东丰,曹连元,邹义壮,张向阳,苏建民.抗精神病药所致迟发性运动障碍患者血浆超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化酶活性及丙二醛浓度的改变[J].中华精神科杂志,2005,38(3):142-145. 被引量:15
  • 2张建清,苏雪,吴琼,丁松爽,孙坤.药用植物党参的RAPD分析[J].中药材,2006,29(5):417-420. 被引量:27
  • 3谭斌.分区化服务对提高精神分裂症患者治疗依从性的探讨[J].西安交通大学学报(医学版),2006,27(6):612-614. 被引量:3
  • 4Bai YM, Chou KH, Lin CP,eL al. White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study. Schizophr Res,2009,109 ( 1-3 ) : 167-181.
  • 5Snyder AM, Connor JR. Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta, 2009, 1790: 606- 614.
  • 6Ke Y. Qian ZM. Brain iron metabolism: neurobiology and neurochemistry. Prog Neurobiol,2007,83 : 149-173.
  • 7Bartzokis G, Gather H J, Marder SR, et al. MRI in tardive dyskinesia: shortened left caudate T2. Biol Psychiatry, 1990, 28 : 1027-1036.
  • 8Elkashef AM, Egan MF, Frank JA, et al. Basal ganglia iron in tardive dyskinesia: an MRI study. Biol Psychiatry, 1994, 35:16- 21.
  • 9Brass SD, Chen NK, Mulkern RV, et al. Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson hnaging,2006 ,17 :31-40.
  • 10Haacke EM, Ayaz M, Khan A, et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson hnaging, 2007,26:256-264.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部